Works about PROGRAMMED death-ligand 1
Results: 3514
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1504618
- By:
- Publication type:
- Article
Role of PD-L1 in mediating the effect of lipid on ulcerative colitis: a mediation Mendelian randomization study.
- Published in:
- Frontiers in Genetics, 2025, p. 1, doi. 10.3389/fgene.2025.1390605
- By:
- Publication type:
- Article
The interplay between programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) genotypes in cervical carcinomas: findings of a Nigerian Tertiary Hospital.
- Published in:
- Pan African Medical Journal, 2024, v. 48, p. 1, doi. 10.11604/pamj.2024.48.90.42773
- By:
- Publication type:
- Article
Correction: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13812-x
- By:
- Publication type:
- Article
Clinical efficacy and safety evaluation of traditional Chinese medicine for nourishing yin and Replenishing qi in combination with PD-1/PD-L1 inhibitors in the treatment of NSCLC patients: a meta-analysis.
- Published in:
- Toxicology Research, 2025, v. 14, n. 1, p. 1, doi. 10.1093/toxres/tfaf013
- By:
- Publication type:
- Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03612-7
- By:
- Publication type:
- Article
Neoadjuvant Camrelizumab for Triple-Negative Breast Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Effects of c-Kit Receptor, AKT, and NF-κB Inhibitors on Immune Evasion in Multiple Myeloma Cells.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2025, v. 24, n. 1, p. 89, doi. 10.18502/ijaai.v24i1.18024
- By:
- Publication type:
- Article
A Critical Role of Intracellular PD-L1 in Promoting Ovarian Cancer Progression.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 4, p. 314, doi. 10.3390/cells14040314
- By:
- Publication type:
- Article
Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel Immune Checkpoint Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 293, doi. 10.3390/biom15020293
- By:
- Publication type:
- Article
Treatment Response to Oncolytic Virus in Patient-Derived Breast Cancer and Hypopharyngeal Cancer Organoids: Evaluation via a Microfluidics Organ-on-a-Chip System.
- Published in:
- Bioengineering (Basel), 2025, v. 12, n. 2, p. 146, doi. 10.3390/bioengineering12020146
- By:
- Publication type:
- Article
Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1508885
- By:
- Publication type:
- Article
Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 500, doi. 10.3390/biomedicines13020500
- By:
- Publication type:
- Article
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 401, doi. 10.3390/biomedicines13020401
- By:
- Publication type:
- Article
Electroacupuncture Modulates Programmed Cell Death 1 Ligand 1 on Peripheral and Central Nervous Systems in a Mouse Fibromyalgia Pain Model.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 396, doi. 10.3390/biomedicines13020396
- By:
- Publication type:
- Article
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1200, doi. 10.3390/jcm14041200
- By:
- Publication type:
- Article
Immunotherapy Combined with Chemotherapy in the First-Line Treatment of Advanced Gastric Cancer: Systematic Review and Bayesian Network Meta-Analysis Based on Specific PD-L1 CPS.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 112, doi. 10.3390/curroncol32020112
- By:
- Publication type:
- Article
Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 94, doi. 10.3390/curroncol32020094
- By:
- Publication type:
- Article
An Unusual Case of Metastatic Gastric Cancer Presenting with Right Heart Failure and Cardiac Metastasis.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Preparation and bioevaluation of a <sup>99m</sup>Tc-labeled small-molecular radiotracer for PD-L1 imaging.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2025, v. 334, n. 2, p. 1621, doi. 10.1007/s10967-024-09901-z
- By:
- Publication type:
- Article
A Comparative Molecular Dynamics Study of Food-Derived Compounds as PD-L1 Inhibitors: Insights Across Six Flavonoid Subgroups.
- Published in:
- Molecules, 2025, v. 30, n. 4, p. 907, doi. 10.3390/molecules30040907
- By:
- Publication type:
- Article
Cancer Cell‐Selective PD‐L1 Inhibition via a DNA Safety Catch to Enhance Immunotherapy Specificity.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 20, p. 1, doi. 10.1002/ange.202402522
- By:
- Publication type:
- Article
Leveraging Radiation‐triggered Metal Prodrug Activation Through Nanosurface Energy Transfer for Directed Radio‐chemo‐immunotherapy.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 10, p. 1, doi. 10.1002/ange.202317943
- By:
- Publication type:
- Article
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 30, p. 1, doi. 10.1002/ange.202305200
- By:
- Publication type:
- Article
Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 11, p. 1, doi. 10.1002/ange.202218128
- By:
- Publication type:
- Article
Rücktitelbild: PD‐L1 Aptamer‐Functionalized Metal–Organic Framework Nanoparticles for Robust Photo‐Immunotherapy against Cancer with Enhanced Safety (Angew. Chem. 5/2023).
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 5, p. 1, doi. 10.1002/ange.202218931
- By:
- Publication type:
- Article
PD‐L1 Aptamer‐Functionalized Metal–Organic Framework Nanoparticles for Robust Photo‐Immunotherapy against Cancer with Enhanced Safety.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 5, p. 1, doi. 10.1002/ange.202214750
- By:
- Publication type:
- Article
Tailored Cross‐β Assemblies Establish Peptide "Dominos" Structures for Anchoring Undruggable Pharmacophores.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 51, p. 1, doi. 10.1002/ange.202212527
- By:
- Publication type:
- Article
Visualization of Protein‐Specific Glycation in Living Cells via Bioorthogonal Chemical Reporter.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 41, p. 1, doi. 10.1002/ange.202210069
- By:
- Publication type:
- Article
Multimodal Imaging‐Guided Photothermal Immunotherapy Based on a Versatile NIR‐II Aggregation‐Induced Emission Luminogen.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 27, p. 1, doi. 10.1002/ange.202202614
- By:
- Publication type:
- Article
Deep Downregulation of PD‐L1 by Caged Peptide‐Conjugated AIEgen/miR‐140 Nanoparticles for Enhanced Immunotherapy.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 18, p. 1, doi. 10.1002/ange.202117798
- By:
- Publication type:
- Article
Tracing Tumor‐Derived Exosomal PD‐L1 by Dual‐Aptamer Activated Proximity‐Induced Droplet Digital PCR.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 14, p. 7660, doi. 10.1002/ange.202015628
- By:
- Publication type:
- Article
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 51, p. 23513, doi. 10.1002/ange.202011273
- By:
- Publication type:
- Article
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 34, p. 14736, doi. 10.1002/ange.202006117
- By:
- Publication type:
- Article
Synergistic effects of BTN3A1, SHP2, CD274, and STAT3 gene polymorphisms on the risk of systemic lupus erythematosus: a multifactorial dimensional reduction analysis.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 489, doi. 10.1007/s10067-023-06765-8
- By:
- Publication type:
- Article
High programmed death ligand 1 expression in carcinomatous components predicts a poor prognosis in pulmonary pleomorphic carcinoma.
- Published in:
- Surgery Today, 2022, v. 52, n. 7, p. 1090, doi. 10.1007/s00595-021-02439-7
- By:
- Publication type:
- Article
Reply to the letter.
- Published in:
- 2020
- By:
- Publication type:
- Letter
PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prognostic impact of CD8+ T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma.
- Published in:
- Surgery Today, 2020, v. 50, n. 8, p. 931, doi. 10.1007/s00595-020-01967-y
- By:
- Publication type:
- Article
PD-1 and PD-L1 inhibitor treatment is associated with increased odds of cutaneous squamous cell carcinoma in a large retrospective cohort study.
- Published in:
- Archives of Dermatological Research, 2024, v. 317, n. 1, p. 1, doi. 10.1007/s00403-024-03497-w
- By:
- Publication type:
- Article
Inhibition of stem-like cells proliferation and programmed cell death-ligand 1 expression by blocking transforming growth factor-β1 signaling pathway in angiosarcoma.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 6, p. 1, doi. 10.1007/s00403-024-02927-z
- By:
- Publication type:
- Article
To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 4, p. 903, doi. 10.1007/s00403-022-02468-3
- By:
- Publication type:
- Article
Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
- Published in:
- Archives of Dermatological Research, 2022, v. 314, n. 8, p. 777, doi. 10.1007/s00403-021-02289-w
- By:
- Publication type:
- Article
The PD-1/PD-L1 pathway in murine hair cycle transition: a potential anagen phase regulator.
- Published in:
- Archives of Dermatological Research, 2021, v. 313, n. 9, p. 751, doi. 10.1007/s00403-020-02169-9
- By:
- Publication type:
- Article
Sialylation-dependent interaction between PD-L1 and CD169 promotes monocyte adhesion to endothelial cells.
- Published in:
- Glycobiology, 2023, v. 33, n. 3, p. 215, doi. 10.1093/glycob/cwad005
- By:
- Publication type:
- Article
The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 1, p. 58, doi. 10.14744/ejmi.2023.36214
- By:
- Publication type:
- Article
Prognostic Significance of PD-L1 Expression in Stage 4 Non-Small-Cell Lung Cancer.
- Published in:
- Bosphorus Medical Journal / Boğaziçi Tıp Dergisi, 2023, v. 10, n. 4, p. 237, doi. 10.14744/bmj.2023.24572
- By:
- Publication type:
- Article
Molecular Signatures of KRAS-Mutated Lung Adenocarcinoma: Analysis of Concomitant EGFR, ALK, STK11, and PD-L1 Status.
- Published in:
- Clinical Pathology, 2022, v. 15, p. 1, doi. 10.1177/2632010X221102054
- By:
- Publication type:
- Article
Molecular Classification of Gastric Cancer With Emphasis on PDL-1 Expression: The First Report From Iran.
- Published in:
- Clinical Pathology, 2022, v. 15, p. 1, doi. 10.1177/2632010X221096378
- By:
- Publication type:
- Article